Latest Psoriatic arthritis Stories
ReportsnReports.com offers Therapeutic Class Overview: Psoriasis – Plaque Psoriasis & Psoriatic Arthritis: Novel Oral drugs and Biologics to Change Future Treatment Paradigm market research
In May, over three dozen nonprofits around the world, along with thousands of patients, supporters, practitioners, and researchers, will unite under one ‘virtual roof’ to participate in the
FORT WORTH, Texas, April 14, 2014 /PRNewswire/ -- ReCept announces that it is among a select group of specialty pharmacies selected by Celgene to distribute Otezla® (apremilast), a new
Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors.
FLINT, Mich., April 4, 2014 /PRNewswire-iReach/ -- Diplomat has announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla® (apremilast),
PETACH TIKVA, Israel, March 25, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment
Cloud-based training collaboration delivers clinically relevant information anywhere. CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ -- The Group for Research and Assessment of
- Growing in low tufty patches.